Drug Clinical Trial Data
B032 Drug clinical result basic information
Obtain clinical result data through clinical result ID
get/synapse/ct-result/detail
Request
- Base URLhttps://connect.patsnap.com
- AuthHTTP bearer
- TypeScriptA function with typed inputs. Its response is checked against the schema.
Query parameters
ct_result_idstring
Clinical trial result ID, obtain this through clinical result search interface
Example:e8ea588d3590e929a8022420da25d555
Response
Successful b032 drug clinical result basic information response.
Example response
{
"data": {
"drug": [
{
"drug_id": "2838b95ade834c96b17ac8bcd2b68c27",
"display_name": [
{
"lang": "EN",
"name": "Sotorasib"
},
{
"lang": "CN",
"name": "索托拉西布"
}
]
}
],
"phase": {
"display_name": [
{
"lang": "EN",
"name": "Autologous CAR-T"
},
{
"lang": "CN",
"name": "自体CAR-T"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
},
"title": "Matching-Adjusted Indirect Treatment Comparisons (MAIC) of Sotorasib 960mg (soto960) Plus Panitumumab (pani) Vs. Trifluridine/Tipiracil(T/T) Plus Bevacizumab (bev) in Chemorefractory Metastatic Colorectal Cancer (mCRC)",
"target": [
{
"target_id": "8556307199154d34b1f9bc9685f2ec47",
"short_name": [
{
"lang": "EN",
"name": "IL-6RA"
}
],
"display_name": [
{
"lang": "EN",
"name": "Interleukin-6 receptor alpha subunit"
},
{
"lang": "CN",
"name": "白细胞介素-6受体α亚基"
}
]
}
],
"biomarker": [
{
"id": "11acf267a4fc42f392751e023482aac3",
"display_name": [
{
"lang": "EN",
"name": "CTNNB1 Mutation"
}
]
}
],
"conclusion": "Sotorasib-panitumumab demonstrated acceptable safety with promising efficacy in chemotherapy-refractory KRASG12C-mutated metastatic colorectal cancer.",
"related_id": [
{
"id_type": "study_identifier",
"id_value": "CodeBreaK 300"
}
],
"ct_result_id": "5400a5a2dee3da90dd52408a3585d805",
"organization": [
{
"display_name": [
{
"lang": "EN",
"name": "Amgen, Inc."
},
{
"lang": "CN",
"name": "安进股份有限公司"
}
],
"organization_id": "11ef8a9e8bf5ca80213a1183511cded3"
}
],
"study_design": {
"masking": "XXXX",
"allocation": "XXXX",
"primary_purpose": "XXXX",
"intervention_model": "XXXX",
"allocation_normalized": {
"display_name": [
{
"lang": "EN",
"name": "Autologous CAR-T"
},
{
"lang": "CN",
"name": "自体CAR-T"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
},
"intervention_model_normalized": {
"display_name": [
{
"lang": "EN",
"name": "Autologous CAR-T"
},
{
"lang": "CN",
"name": "自体CAR-T"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
}
},
"therapy_type": [
{
"display_name": [
{
"lang": "EN",
"name": "Third line"
},
{
"lang": "CN",
"name": "三线"
}
],
"normalized_id": "62662f0b1d5b3fafabeb571a211e9a31"
}
],
"published_time": 1719446400000,
"register_number": [
"NCT05198934"
],
"single_or_multi": "single_drug",
"mechanism_action": [
{
"short_name": [
{
"lang": "EN",
"name": "IL-6RA antagonists"
},
{
"lang": "CN",
"name": "IL-6RA拮抗剂"
}
],
"display_name": [
{
"lang": "EN",
"name": "Interleukin-6 receptor alpha subunit antagonists"
},
{
"lang": "CN",
"name": "白细胞介素-6受体α亚基拮抗剂"
}
],
"mechanism_id": "b30a0bdb2e0bd9c03a908a84588c4217"
}
],
"therapeutic_area": [
{
"disease_id": "042cbe45c973477b957717ded29ef7b6",
"display_name": [
{
"lang": "EN",
"name": "Nervous System Diseases"
},
{
"lang": "CN",
"name": "神经系统疾病"
}
]
}
],
"condition_disease": [
{
"disease_id": "e35ce4e9b7a846d49e600ce7ac4a7fd6",
"display_name": [
{
"lang": "EN",
"name": "Metastatic Colorectal Carcinoma"
},
{
"lang": "CN",
"name": "转移性结直肠癌"
}
]
}
],
"general_evaluation": {
"display_name": [
{
"lang": "EN",
"name": "Autologous CAR-T"
},
{
"lang": "CN",
"name": "自体CAR-T"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
},
"original_biomarker": [
{
"name": "IL-6"
}
],
"overall_enrollment": 100,
"register_number_map": {
"NCT04737187": "5a4a2ad359d8a855d925943e23a58845"
},
"sponsor_organization": [
{
"display_name": [
{
"lang": "EN",
"name": "Amgen, Inc."
},
{
"lang": "CN",
"name": "安进股份有限公司"
}
],
"organization_id": "11ef8a9e8bf5ca80213a1183511cded3"
}
],
"collaborator_organization": [
{
"display_name": [
{
"lang": "EN",
"name": "Amgen, Inc."
},
{
"lang": "CN",
"name": "安进股份有限公司"
}
],
"organization_id": "11ef8a9e8bf5ca80213a1183511cded3"
}
]
},
"error_msg": "The request parameter format is incorrect！"
}Changes
No recorded changes to this operation across all 1 revision of this API.